Delivery Order SPE2DR25D1002-SPE2DR26FGJ2E
- Not listed
- The Defense Logistics Agency (DLA) awarded a $24,814.95 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 24, 2025, with an ultimate completion date of October 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp on September 23, 2025, for ProQuad vials with an ultimate completion date of October 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at the...
- The Defense Logistics Agency awarded a $16,709 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for ProQuad vials with an ultimate completion date of October 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.26 to AmerisourceBergen Drug Corp for ProQuad vials on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $3,341.80 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,654.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 20, 2025, with a completion date of September 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The order will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $3,308.68 to AmerisourceBergen Drug Corp for ProQuad vials on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,543.30 delivery order (Contract 4569422403) to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $52,272.03 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, making...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ2EDelivery Order
The Defense Logistics Agency awarded a $3,205.14 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on October 30, 2025, with completion expected by November 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, critical for military medical readiness and vaccination programs across the Department of Defense healthcare system. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad spectrum of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices to support military healthcare programs globally. This delivery order reflects the company's ongoing role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, supporting operational readiness across the military medical enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/30/25 |